Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy

Table 2 Demographic features and cycle characteristics

	Vaginal (n = 227)	IM (n = 182)	P value
Age (MEAN and SD)^a	31.3 ± 4.7	31.6 ± 5	0.5
BMI (MEAN and SD)^a	28.6 ± 4	27.9 ± 4.3	0.2
Duration of infertility(MEAN and SD)^a	6 ± 4	6 ± 4	0.35
NO. of cycle (MEAN and SD)^a	2 ± 1.7	2 ± 1.5	0.84
Long protocol n (%)^b	152 (67%)	110 (60%)	0.067
GnRh Antagonist n (%)^b	75 (33%)	72 (40%)	0.3

ISSN: 2054-7099